Macular Infarction following Intravitreal Clindamycin Injection : A Case Report

PURPOSE: To report a case of Toxoplasma retinochoroiditis that was complicated by macular infarction following intravitreal clindamycin injection. METHODS: A 32-year-old otherwise healthy woman with the diagnosis of reactivation of Toxoplasma retinochoroiditis in her right eye, underwent intravitrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedayatfar, Alireza, Zand, Amin, Faghihi, Hooshang, Gordiz, Arzhang, Abdi, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579790/
https://www.ncbi.nlm.nih.gov/pubmed/34765827
http://dx.doi.org/10.4103/joco.joco_150_20
Descripción
Sumario:PURPOSE: To report a case of Toxoplasma retinochoroiditis that was complicated by macular infarction following intravitreal clindamycin injection. METHODS: A 32-year-old otherwise healthy woman with the diagnosis of reactivation of Toxoplasma retinochoroiditis in her right eye, underwent intravitreal clindamycin injection. Shortly after injection, the visual acuity deteriorated, and the fundus examination revealed an extensive area of macular necrosis accompanied by vascular occlusion. RESULTS: The patient was observed. Unfortunately, the condition did not improve over time and resulted in a large area of retinal atrophy. CONCLUSION: Macular infarction should be considered a rare but disastrous complication that can result in severe, irreversible visual loss.

Ejemplares similares